Global Antisense & RNAi Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

  • ID:PD030773
  • August 2020
  • GIR (Global Info Research)
                          

The Global Antisense & RNAi Therapeutics Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2020 to 2025. The detailed sales channel is also covered in the study.

The global Antisense & RNAi Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.1% in the forecast period of 2020 to 2025 and will expected to reach USD 1156.9 million by 2025, from USD 986.3 million in 2019.

The Antisense & RNAi Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market Segmentation
Antisense & RNAi Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Antisense & RNAi Therapeutics market has been segmented into:

  •     RNA interference
  •     SiRNA
  •     MiRNA
  •     Antisense RNA

By Application, Antisense & RNAi Therapeutics has been segmented into:
  •     Oncology
  •     Cardiovascular
  •     Renal
  •     Neurodegenerative
  •     Respiratory
  •     Genetic
  •     Infectious Diseases

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antisense & RNAi Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Antisense & RNAi Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antisense & RNAi Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Antisense & RNAi Therapeutics market in important countries (regions), including:
  •     North America (United States, Canada and Mexico)
  •     Europe (Germany, France, UK, Russia and Italy)
  •     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
  •     South America (Brazil, Argentina, Colombia)
  •     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Antisense & RNAi Therapeutics Market Share Analysis
Antisense & RNAi Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antisense & RNAi Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antisense & RNAi Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Antisense & RNAi Therapeutics are:
  • Glaxo Smith Kline
  • ICo Therapeutics
  • Arbutus Biopharma Ltd.
  • Sanofi Aventis / Genzyme
  • Calando Pharmaceuticals
  • Isis Pharmaceuticals/ Ionis Pharmaceuticals
  • Rexhan Pharmaceuticals
  • Bio-Path Holdings Inc.
  • Silence Therapeutics
  • Quark Pharmaceuticals
  • Dicerna Pharmaceuticals
  • Biomarin/Prosensa
  • Sirnaomics Inc.
  • Silenseed
  • Regulus Therapeutics
  • Rxi Pharmaceuticals

There are 14 Chapters to deeply display the Global Antisense & RNAi Therapeutics market.
1 Antisense & RNAi Therapeutics Market Overview
2 Company Profiles
3 Market Competition, by Players
4 Market Size by Regions
5 North America Antisense & RNAi Therapeutics Revenue by Countries
6 Europe Antisense & RNAi Therapeutics Revenue by Countries
7 Asia-Pacific Antisense & RNAi Therapeutics Revenue by Countries
8 South America Antisense & RNAi Therapeutics Revenue by Countries
9 Middle East & Africa Revenue Antisense & RNAi Therapeutics by Countries
10 Market Size Segment by Type
11 Global Antisense & RNAi Therapeutics Market Segment by Application
12 Global Antisense & RNAi Therapeutics Market Size Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix

Table of Contents

1 Antisense & RNAi Therapeutics Market Overview
    1.1 Product Overview and Scope of Antisense & RNAi Therapeutics
    1.2 Classification of Antisense & RNAi Therapeutics by Type
        1.2.1 Global Antisense & RNAi Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
        1.2.2 Global Antisense & RNAi Therapeutics Revenue Market Share by Type in 2019
        1.2.3 RNA interference
        1.2.4 SiRNA
        1.2.5 MiRNA
        1.2.6 Antisense RNA
    1.3 Global Antisense & RNAi Therapeutics Market by Application
        1.3.1 Overview: Global Antisense & RNAi Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
        1.3.2 Oncology
        1.3.3 Cardiovascular
        1.3.4 Renal
        1.3.5 Neurodegenerative
        1.3.6 Respiratory
        1.3.7 Genetic
        1.3.8 Infectious Diseases
    1.4 Global Antisense & RNAi Therapeutics Market by Regions
        1.4.1 Global Antisense & RNAi Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
        1.4.2 Global Market Size of Antisense & RNAi Therapeutics (2015-2025)
        1.4.3 North America (USA, Canada and Mexico) Antisense & RNAi Therapeutics Status and Prospect (2015-2025)
        1.4.4 Europe (Germany, France, UK, Russia and Italy) Antisense & RNAi Therapeutics Status and Prospect (2015-2025)
        1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antisense & RNAi Therapeutics Status and Prospect (2015-2025)
        1.4.6 South America (Brazil, Argentina, Colombia) Antisense & RNAi Therapeutics Status and Prospect (2015-2025)
        1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antisense & RNAi Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
    2.1 Glaxo Smith Kline
        2.1.1 Glaxo Smith Kline Details
        2.1.2 Glaxo Smith Kline Major Business and Total Revenue (Financial Highlights) Analysis
        2.1.3 Glaxo Smith Kline SWOT Analysis
        2.1.4 Glaxo Smith Kline Product and Services
        2.1.5 Glaxo Smith Kline Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
    2.2 ICo Therapeutics
        2.2.1 ICo Therapeutics Details
        2.2.2 ICo Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
        2.2.3 ICo Therapeutics SWOT Analysis
        2.2.4 ICo Therapeutics Product and Services
        2.2.5 ICo Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
    2.3 Arbutus Biopharma Ltd.
        2.3.1 Arbutus Biopharma Ltd. Details
        2.3.2 Arbutus Biopharma Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
        2.3.3 Arbutus Biopharma Ltd. SWOT Analysis
        2.3.4 Arbutus Biopharma Ltd. Product and Services
        2.3.5 Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
    2.4 Sanofi Aventis / Genzyme
        2.4.1 Sanofi Aventis / Genzyme Details
        2.4.2 Sanofi Aventis / Genzyme Major Business and Total Revenue (Financial Highlights) Analysis
        2.4.3 Sanofi Aventis / Genzyme SWOT Analysis
        2.4.4 Sanofi Aventis / Genzyme Product and Services
        2.4.5 Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
    2.5 Calando Pharmaceuticals
        2.5.1 Calando Pharmaceuticals Details
        2.5.2 Calando Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
        2.5.3 Calando Pharmaceuticals SWOT Analysis
        2.5.4 Calando Pharmaceuticals Product and Services
        2.5.5 Calando Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
    2.6 Isis Pharmaceuticals/ Ionis Pharmaceuticals
        2.6.1 Isis Pharmaceuticals/ Ionis Pharmaceuticals Details
        2.6.2 Isis Pharmaceuticals/ Ionis Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
        2.6.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals SWOT Analysis
        2.6.4 Isis Pharmaceuticals/ Ionis Pharmaceuticals Product and Services
        2.6.5 Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
    2.7 Rexhan Pharmaceuticals
        2.7.1 Rexhan Pharmaceuticals Details
        2.7.2 Rexhan Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
        2.7.3 Rexhan Pharmaceuticals SWOT Analysis
        2.7.4 Rexhan Pharmaceuticals Product and Services
        2.7.5 Rexhan Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
    2.8 Bio-Path Holdings Inc.
        2.8.1 Bio-Path Holdings Inc. Details
        2.8.2 Bio-Path Holdings Inc. Major Business and Total Revenue (Financial Highlights) Analysis
        2.8.3 Bio-Path Holdings Inc. SWOT Analysis
        2.8.4 Bio-Path Holdings Inc. Product and Services
        2.8.5 Bio-Path Holdings Inc. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
    2.9 Silence Therapeutics
        2.9.1 Silence Therapeutics Details
        2.9.2 Silence Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
        2.9.3 Silence Therapeutics SWOT Analysis
        2.9.4 Silence Therapeutics Product and Services
        2.9.5 Silence Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
    2.10 Quark Pharmaceuticals
        2.10.1 Quark Pharmaceuticals Details
        2.10.2 Quark Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
        2.10.3 Quark Pharmaceuticals SWOT Analysis
        2.10.4 Quark Pharmaceuticals Product and Services
        2.10.5 Quark Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
    2.11 Dicerna Pharmaceuticals
        2.11.1 Dicerna Pharmaceuticals Details
        2.11.2 Dicerna Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
        2.11.3 Dicerna Pharmaceuticals SWOT Analysis
        2.11.4 Dicerna Pharmaceuticals Product and Services
        2.11.5 Dicerna Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
    2.12 Biomarin/Prosensa
        2.12.1 Biomarin/Prosensa Details
        2.12.2 Biomarin/Prosensa Major Business and Total Revenue (Financial Highlights) Analysis
        2.12.3 Biomarin/Prosensa SWOT Analysis
        2.12.4 Biomarin/Prosensa Product and Services
        2.12.5 Biomarin/Prosensa Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
    2.13 Sirnaomics Inc.
        2.13.1 Sirnaomics Inc. Details
        2.13.2 Sirnaomics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
        2.13.3 Sirnaomics Inc. SWOT Analysis
        2.13.4 Sirnaomics Inc. Product and Services
        2.13.5 Sirnaomics Inc. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
    2.14 Silenseed
        2.14.1 Silenseed Details
        2.14.2 Silenseed Major Business and Total Revenue (Financial Highlights) Analysis
        2.14.3 Silenseed SWOT Analysis
        2.14.4 Silenseed Product and Services
        2.14.5 Silenseed Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
    2.15 Regulus Therapeutics
        2.15.1 Regulus Therapeutics Details
        2.15.2 Regulus Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
        2.15.3 Regulus Therapeutics SWOT Analysis
        2.15.4 Regulus Therapeutics Product and Services
        2.15.5 Regulus Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
    2.16 Rxi Pharmaceuticals
        2.16.1 Rxi Pharmaceuticals Details
        2.16.2 Rxi Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
        2.16.3 Rxi Pharmaceuticals SWOT Analysis
        2.16.4 Rxi Pharmaceuticals Product and Services
        2.16.5 Rxi Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
    3.1 Global Antisense & RNAi Therapeutics Revenue and Share by Players (2015-2020)
    3.2 Market Concentration Rate
        3.2.1 Top 5 Antisense & RNAi Therapeutics Players Market Share
        3.2.2 Top 10 Antisense & RNAi Therapeutics Players Market Share
    3.3 Market Competition Trend
4 Market Size by Regions
    4.1 Global Antisense & RNAi Therapeutics Revenue and Market Share by Regions
    4.2 North America Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    4.3 Europe Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    4.4 Asia-Pacific Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    4.5 South America Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    4.6 Middle East & Africa Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Antisense & RNAi Therapeutics Revenue by Countries
    5.1 North America Antisense & RNAi Therapeutics Revenue by Countries (2015-2020)
    5.2 USA Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    5.3 Canada Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    5.4 Mexico Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Antisense & RNAi Therapeutics Revenue by Countries
    6.1 Europe Antisense & RNAi Therapeutics Revenue by Countries (2015-2020)
    6.2 Germany Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    6.3 UK Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    6.4 France Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    6.5 Russia Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    6.6 Italy Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Antisense & RNAi Therapeutics Revenue by Countries
    7.1 Asia-Pacific Antisense & RNAi Therapeutics Revenue by Countries (2015-2020)
    7.2 China Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    7.3 Japan Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    7.4 Korea Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    7.5 India Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    7.6 Southeast Asia Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Antisense & RNAi Therapeutics Revenue by Countries
    8.1 South America Antisense & RNAi Therapeutics Revenue by Countries (2015-2020)
    8.2 Brazil Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    8.3 Argentina Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Antisense & RNAi Therapeutics by Countries
    9.1 Middle East & Africa Antisense & RNAi Therapeutics Revenue by Countries (2015-2020)
    9.2 Saudi Arabia Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    9.3 UAE Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    9.4 Egypt Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
    9.5 South Africa Antisense & RNAi Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
    10.1 Global Antisense & RNAi Therapeutics Revenue and Market Share by Type (2015-2020)
    10.2 Global Antisense & RNAi Therapeutics Market Forecast by Type (2019-2024)
    10.3 RNA interference Revenue Growth Rate (2015-2025)
    10.4 SiRNA Revenue Growth Rate (2015-2025)
    10.5 MiRNA Revenue Growth Rate (2015-2025)
    10.6 Antisense RNA Revenue Growth Rate (2015-2025)
11 Global Antisense & RNAi Therapeutics Market Segment by Application
    11.1 Global Antisense & RNAi Therapeutics Revenue Market Share by Application (2015-2020)
    11.2 Antisense & RNAi Therapeutics Market Forecast by Application (2019-2024)
    11.3 Oncology Revenue Growth (2015-2020)
    11.4 Cardiovascular Revenue Growth (2015-2020)
    11.5 Renal Revenue Growth (2015-2020)
    11.6 Neurodegenerative Revenue Growth (2015-2020)
    11.7 Respiratory Revenue Growth (2015-2020)
    11.8 Genetic Revenue Growth (2015-2020)
    11.9 Infectious Diseases Revenue Growth (2015-2020)
12 Global Antisense & RNAi Therapeutics Market Size Forecast (2021-2025)
    12.1 Global Antisense & RNAi Therapeutics Market Size Forecast (2021-2025)
    12.2 Global Antisense & RNAi Therapeutics Market Forecast by Regions (2021-2025)
    12.3 North America Antisense & RNAi Therapeutics Revenue Market Forecast (2021-2025)
    12.4 Europe Antisense & RNAi Therapeutics Revenue Market Forecast (2021-2025)
    12.5 Asia-Pacific Antisense & RNAi Therapeutics Revenue Market Forecast (2021-2025)
    12.6 South America Antisense & RNAi Therapeutics Revenue Market Forecast (2021-2025)
    12.7 Middle East & Africa Antisense & RNAi Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Data Source
    14.3 Disclaimer
    14.4 About US

Related Categories
Medical Devices
Related Reports
Global Air Filter Masks Market Insights, Forecast to 2025

Air Filter Masks Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global CT Machine Market Insights, Forecast to 2025

CT Machine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Bead Wire Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026

The report on the Global Bead Wire Market gives an estimation of the development of the market based on historical studies and also provides forecasts on  read more..


Global Nasopharyngoscope Market Research Report 2017

The Nasopharyngoscope Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


Global Digital Radiography Systems Market Research Report 2017

The Digital Radiography Systems Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


Global Dental Extraction Forceps Market Research Report 2017

The Dental Extraction Forceps Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


Global Endoscopic Market Research Report 2017

The Global Endoscopic Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


Global Bronchoscope Sales Market Report 2017

The Global Bronchoscope Sales Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


Global 3D Printing Medical Devices Market Research Report 2017

The Global 3D Printing Medical Devices Market Research Report provides a detailed market overview along with the analysis of industry’s gross  read more..


Global Cystoscope Sales Market Report 2017

The Global Cystoscope Sales Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..